SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo

DMM Disease Models and Mechanisms

Volumn 3, Issue 11-12, 2010, Pages 733-742

  Jurynec, Michael J ^a   Grunwald, David Jonah ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIET; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; INSULIN SENSITIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; BODY PATTERNING; BONE MORPHOGENETIC PROTEINS; DIET; EMBRYO, NONMAMMALIAN; FEMALE; FIBROBLAST GROWTH FACTORS; GASTRULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN; MOLECULAR SEQUENCE DATA; OBESITY; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; WNT PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO; MAMMALIA;

EID: 78649239911     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.000703     Document Type: Article

References (70)

1. Affolter, M. and Basler, K. (2007). The Decapentaplegic morphogen gradient: from pattern formation to growth regulation. Nat. Rev. Genet. 8, 663-674. (Pubitemid 47281990)
2. Aoki, K., Nakamura, T., Inoue, T., Meyer, T. and Matsuda, M. (2007). An essential role for the SHIP2-dependent negative feedback loop in neuritogenesis of nerve growth factor-stimulated PC12 cells. J. Cell Biol. 177, 817-827.
3. Artemenko, Y., Gagnon, A. and Sorisky, A. (2009). Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes. J. Cell Physiol. 218, 228-236.
4. Backers, K., Blero, D., Paternotte, N., Zhang, J. and Erneux, C. (2003). The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv. Enzyme Regul. 43, 15-28.
5. Beenken, A. and Mohammadi, M. (2009). The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253.
6. Birnbaum, M. J. (2005). SHIPing news: a new way to keep your weight down. Cell Metab. 1, 90-92.
7. Blero, D., De Smedt, F., Pesesse, X., Paternotte, N., Moreau, C., Payrastre, B. and Erneux, C. (2001). The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem. Biophys. Res. Commun. 282, 839-843. (Pubitemid 32924634)
8. Christian, J. L. and Moon, R. T. (1993). Interactions between Xwnt-8 and Spemann organizer signaling pathways generate dorsoventral pattern in the embryonic mesoderm of Xenopus. Genes Dev. 7, 13-28.
9. Clement, S., Krause, U., Desmedt, F., Tanti, J. F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W. et al. (2001). The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92-97.
10. Cohen, J. M. M. (2004). FGFs/FGFRs and associated disorders. In Inborn Errors of Metabolism (eds C. J. Epstein, J. D. Erickson and A. Wynshaw-Boris), pp. 380-400. New York: Oxford University Press.
11. Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E. and Kharitonenkov, A. (2008). Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027.
12. De Robertis, E. M., Larrain, J., Oelgeschlager, M. and Wessely, O. (2000). The establishment of Spemann's organizer and patterning of the vertebrate embryo. Nat. Rev. Genet. 1, 171-181.
13. Decker, S. J. and Saltiel, A. R. (2005). Staying in SHIP shape. Nat. Med. 11, 123-124.
14. Doria, A., Patti, M. E. and Kahn, C. R. (2008). The emerging genetic architecture of type 2 diabetes. Cell Metab. 8, 186-200.
15. Engelman, J. A., Luo, J. and Cantley, L. C. (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619.
16. Fekany, K., Yamanaka, Y., Leung, T., Sirotkin, H. I., Topczewski, J., Gates, M. A., Hibi, M., Renucci, A., Stemple, D., Radbill, A. et al. (1999). The zebrafish bozozok locus encodes Dharma, a homeodomain protein essential for induction of gastrula organizer and dorsoanterior embryonic structures. Development 126, 1427-1438.
17. Fukui, K., Wada, T., Kagawa, S., Nagira, K., Ikubo, M., Ishihara, H., Kobayashi, M. and Sasaoka, T. (2005). Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54, 1958-1967. (Pubitemid 40911257)
18. Furthauer, M., Reifers, F., Brand, M., Thisse, B. and Thisse, C. (2001). sprouty4 acts in vivo as a feedback-induced antagonist of FGF signaling in zebrafish. Development 128, 2175-2186.
19. Furthauer, M., Van Celst, J., Thisse, C. and Thisse, B. (2004). Fgf signalling controls the dorsoventral patterning of the zebrafish embryo. Development 131, 2853-2864.
20. Hammerschmidt, M. and Mullins, M. C. (2002). Dorsoventral patterning in the zebrafish: bone morphogenetic proteins and beyond. Results Probl. Cell Differ. 40, 72-95.
21. Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G. and Humphries, R. K. (1998). Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610-1620.
22. Hinsby, A. M., Olsen, J. V. and Mann, M. (2004). Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4. J. Biol. Chem. 279, 46438-46447. (Pubitemid 39518286)
23. Imai, Y., Gates, M. A., Melby, A. E., Kimelman, D., Schier, A. F. and Talbot, W. S. (2001). The homeobox genes vox and vent are redundant repressors of dorsal fates in zebrafish. Development 128, 2407-2420.
24. Joly, J. S., Joly, C., Schulte-Merker, S., Boulekbache, H. and Condamine, H. (1993). The ventral and posterior expression of the zebrafish homeobox gene eve1 is perturbed in dorsalized and mutant embryos. Development 119, 1261-1275.
25. Jurynec, M. J., Xia, R., Mackrill, J. J., Gunther, D., Crawford, T., Flanigan, K. M., Abramson, J. J., Howard, M. T. and Grunwald, D. J. (2008). Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl. Acad. Sci. USA 105, 12485-12490.
26. Kagawa, S., Sasaoka, T., Yaguchi, S., Ishihara, H., Tsuneki, H., Murakami, S., Fukui, K., Wada, T., Kobayashi, S., Kimura, I. et al. (2005). Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90, 2911-2919. (Pubitemid 40686343)
27. Kagawa, S., Soeda, Y., Ishihara, H., Oya, T., Sasahara, M., Yaguchi, S., Oshita, R., Wada, T., Tsuneki, H. and Sasaoka, T. (2008). Impact of transgenic overexpression of SH2-containing inositol 5′-phosphatase 2 on glucose metabolism and insulin signaling in mice. Endocrinology 149, 642-650.
28. Kan, S. H., Elanko, N., Johnson, D., Cornejo-Roldan, L., Cook, J., Reich, E. W., Tomkins, S., Verloes, A., Twigg, S. R., Rannan-Eliya, S. et al. (2002). Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am. J. Hum. Genet. 70, 472-486.
29. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A. et al. (2005). FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635.
30. Koch, A., Mancini, A., El Bounkari, O. and Tamura, T. (2005). The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene 24, 3436-3447. (Pubitemid 40756245)
31. Koos, D. S. and Ho, R. K. (1999). The nieuwkoid/dharma homeobox gene is essential for bmp2b repression in the zebrafish pregastrula. Dev. Biol. 215, 190-207.
32. Lazar, D. F. and Saltiel, A. R. (2006). Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat. Rev. Drug Discov. 5, 333-342.
33. Leslie, N. R. and Downes, C. P. (2004). PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1-11.
34. Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J. and Penninger, J. M. (1999). SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13, 786-791.
35. Logan, C. Y. and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810.
36. Luo, Y., Yang, C., Jin, C., Xie, R., Wang, F. and McKeehan, W. L. (2009). Novel phosphotyrosine targets of FGFR2IIIb signaling. Cell Signal. 21, 1370-1378.
37. Lusis, A. J., Attie, A. D. and Reue, K. (2008). Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet. 9, 819-830.
38. Manahan, C. L., Iglesias, P. A., Long, Y. and Devreotes, P. N. (2004). Chemoattractant signaling in dictyostelium discoideum. Annu. Rev. Cell Dev. Biol. 20, 223-253.
39. Marion, E., Kaisaki, P. J., Pouillon, V., Gueydan, C., Levy, J. C., Bodson, A., Krzentowski, G., Daubresse, J. C., Mockel, J., Behrends, J. et al. (2002). The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51, 2012-2017.
40. Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R. and Schlessinger, J. (1997). Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276, 955-960. (Pubitemid 27209095)
41. Montero, J. A., Kilian, B., Chan, J., Bayliss, P. E. and Heisenberg, C. P. (2003). Phosphoinositide 3-kinase is required for process outgrowth and cell polarization of gastrulating mesendodermal cells. Curr. Biol. 13, 1279-1289.
42. Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S. et al. (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8, 269-274. (Pubitemid 24338739)
43. Muoio, D. M. and Newgard, C. B. (2008). Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193-205.
44. Muraille, E., Pesesse, X., Kuntz, C. and Erneux, C. (1999). Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J. 342, 697-705.
45. Nguyen, V. H., Schmid, B., Trout, J., Connors, S. A., Ekker, M. and Mullins, M. C. (1998). Ventral and lateral regions of the zebrafish gastrula, including the neural crest progenitors, are established by a bmp2b/swirl pathway of genes. Dev. Biol. 199, 93-110.
46. Odenthal, J. and Nusslein-Volhard, C. (1998). fork head domain genes in zebrafish. Dev. Genes Evol. 208, 245-258. (Pubitemid 28388892)
47. Ooms, L. M., Horan, K. A., Rahman, P., Seaton, G., Gurung, R., Kethesparan, D. S. and Mitchell, C. A. (2009). The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 419, 29-49.
48. Ornitz, D. M. (2000). FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22, 108-112.
49. Pesesse, X., Moreau, C., Drayer, A. L., Woscholski, R., Parker, P. and Erneux, C. (1998). The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett. 437, 301-303.
50. Pesesse, X., Dewaste, V., De Smedt, F., Laffargue, M., Giuriato, S., Moreau, C., Payrastre, B. and Erneux, C. (2001). The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J. Biol. Chem. 276, 28348-28355. (Pubitemid 33652521)
51. Raible, F. and Brand, M. (2001). Tight transcriptional control of the ETS domain factors Erm and Pea3 by Fgf signaling during early zebrafish development. Mech. Dev. 107, 105-117.
52. Ramel, M. C. and Lekven, A. C. (2004). Repression of the vertebrate organizer by Wnt8 is mediated by Vent and Vox. Development 131, 3991-4000.
53. Roehl, H. and Nusslein-Volhard, C. (2001). Zebrafish pea3 and erm are general targets of FGF8 signaling. Curr. Biol. 11, 503-507.
54. Sasaoka, T., Hori, H., Wada, T., Ishiki, M., Haruta, T., Ishihara, H. and Kobayashi, M. (2001). SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44, 1258-1267. (Pubitemid 33010502)
55. Sasaoka, T., Kikuchi, K., Wada, T., Sato, A., Hori, H., Murakami, S., Fukui, K., Ishihara, H., Aota, R., Kimura, I. et al. (2003). Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Endocrinology 144, 4204-4214.
56. Sasaoka, T., Wada, T. and Tsuneki, H. (2006). Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol. Ther. 112, 799-809.
57. Sharma, P. M., Son, H. S., Ugi, S., Ricketts, W. and Olefsky, J. M. (2005). Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes. Mol. Endocrinol. 19, 421-430.
58. Shinya, M., Koshida, S., Sawada, A., Kuroiwa, A. and Takeda, H. (2001). Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos. Development 128, 4153-4164. (Pubitemid 33077028)
59. Sleeman, M. W., Wortley, K. E., Lai, K. M., Gowen, L. C., Kintner, J., Kline, W. O., Garcia, K., Stitt, T. N., Yancopoulos, G. D., Wiegand, S. J. et al. (2005). Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11, 199-205. (Pubitemid 40321356)
60. Stachel, S. E., Grunwald, D. J. and Myers, P. Z. (1993). Lithium perturbation and goosecoid expression identify a dorsal specification pathway in the pregastrula zebrafish. Development 117, 1261-1274.
61. Thisse, B. and Thisse, C. (2005). Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287, 390-402.
62. Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D. et al. (2002). Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143, 1741-1747.
63. Tsang, M. and Dawid, I. B. (2004). Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, pe17.
64. Tsang, M., Maegawa, S., Kiang, A., Habas, R., Weinberg, E. and Dawid, I. B. (2004). A role for MKP3 in axial patterning of the zebrafish embryo. Development 131, 2769-2779.
65. Turner, N. and Grose, R. (2010). Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116-129.
66. Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H. et al. (2001). Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21, 1633-1646. (Pubitemid 32156383)
67. Wang, Y., Keogh, R. J., Hunter, M. G., Mitchell, C. A., Frey, R. S., Javaid, K., Malik, A. B., Schurmans, S., Tridandapani, S. and Marsh, C. B. (2004). SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. J. Immunol. 173, 6820-6830.
68. Westerfield, M. (2000). The Zebrafish Book. Eugene: University of Oregon Press.
69. Wisniewski, D., Strife, A., Swendeman, S., Erdjument-Bromage, H., Geromanos, S., Kavanaugh, W. M., Tempst, P. and Clarkson, B. (1999). A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93, 2707-2720.
70. Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y. S., Lindberg, R. A. et al. (2009). Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259.